Log In

Forgot Password?

OR

Not a member? Continue as a nonmember.

Become a Member

By becoming a member of the AAN, you can receive exclusive information to help you at every stage of your career. Benefits include:

Join Now See All Benefits

Loading... please wait

2023 Annual Meeting | S23 - Pain

Tuesday 04/25/23
01:00 PM - 01:45 PM EST Add To Calendar
This program will be presented both in-person and online
This program will be available in the meeting's On Demand product.
Scientific Platform Session
Pain
A group of abstracts covering a similar topic presented in an oral format. Presentations are eight minutes in length with four minutes for question and answer with the author.
0.75 CME credit
Fellow, Resident, General Neurologist, Specialist Neurologist, Non-neurologist, Advanced Practice Provider, Neurohospitalist, Medical Student
Didactic

Program Materials Program Evaluations

Event Timeline
01:00 PM - 01:12 PM EST Abstract 001 - Peripheral myeloid cells control resolution of painful Chemotherapy-Induced Peripheral Neuropathy (CIPN)
George Naratadam
01:12 PM - 01:24 PM EST Abstract 002 - Novel Variants and Phenotypic Heterogeneity in Congenital Insensitivity to Pain
Sinem Seleme Ovunc, MD
01:24 PM - 01:36 PM EST Abstract 003 - Cilnidipine, a Novel N-Type Specific Calcium Channel Antagonist, Has Potent Activity at the Nav1.7 Sodium Channel, Which May Have Implications for Treatment of Certain Neuropathic Pain Conditions
Andrew Sternlicht, MD
Faculty Disclosures
Alyssa Lebel, MD An immediate family member of Dr. Lebel has received personal compensation for serving as an employee of Stoke therapeutics. An immediate family member of Dr. Lebel has received personal compensation in the range of $100,000-$499,999 for serving as an officer or member of the Board of Directors for cytokinetics. An immediate family member of Dr. Lebel has stock in Stoke and Cytokinetics.
Nathaniel Marc Schuster, MD Dr. Schuster has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Schedule 1 Therapeutics. Dr. Schuster has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Averitas. Dr. Schuster has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lundbeck. Dr. Schuster has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly. Dr. Schuster has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ShiraTronics. Dr. Schuster has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Syneos. Dr. Schuster has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Vectura Fertin. Dr. Schuster has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Eli Lilly & Co. Dr. Schuster has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Averitas. Dr. Schuster has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for LITILI. Dr. Schuster has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Sutton Pierce. The institution of Dr. Schuster has received research support from Migraine Research Foundation. The institution of Dr. Schuster has received research support from Novaremed. The institution of Dr. Schuster has received research support from UCSD Academic Senate.
George Naratadam Mr. Naratadam has nothing to disclose.
Sinem Seleme Ovunc, MD Dr. Ovunc has nothing to disclose.
Armen Akopian, PhD Prof. Akopian has nothing to disclose.
Andrew Sternlicht, MD Dr. Sternlicht has received personal compensation for serving as an employee of Hotelrecovery, Inc. . Dr. Sternlicht has stock in Aisa Pharma. Dr. Sternlicht has received intellectual property interests from a discovery or technology relating to health care.
Deniz Agirbaslo, MD,PhD Dr. Agirbaslo has nothing to disclose.
Mehmet Seven, MD Prof. Seven has nothing to disclose.
Betul Kesriklioglu, Jr., MD Dr. Kesriklioglu has nothing to disclose.
Aysel Kalayci Yigin, PhD Dr. Kalayci Yigin has nothing to disclose.
Gizem Izgi No disclosure on file
Sema Saltik No disclosure on file
Fitnat Ulug No disclosure on file